Navigation Links
Tuberculosis Drug Resistance 'alarming' in India

An alarming 20 percent of the people availing re-treatment of tuberculosis are at the risk// of developing drug resistance in India. According to a leading global health advocacy, India witness nearly 1.8 million fresh cases every year.

On the eve of the World TB Day, March 24, the Global Health Advocates (GHA), a Switzerland-based non-profit body, said that TB drug resistance is becoming a major threat for several countries and India is one of the forerunners.

"After Russia that has recorded a whopping 41 percent drug resistance among the re-treatment category, India and South Africa are facing the wrath with 20 percent of the patients of the same category at risk," said GHA president Bobby John.

Countries with over 10 percent risk include Brazil, Nigeria, Pakistan, Myanmar, Uganda, Thailand and Philippines.

Citing latest data provided by the World Health Organization (WHO), John said: "Nearly 196,000 people registered themselves for re-treatment for TB in 2004 of which 39,000 showed drug resistance.

"Only 50 percent of those who availed of re-treatment were completely cured and 6.9 percent died. It is certainly alarming that close to 43 percent patients need extensive care," John told IANS.

He said India has a considerably good track record in providing TB treatment but there is a need for better health infrastructure to deal with this menace.

"Once a patient becomes drug resistant, he will spread it to many people and you can imagine the economic loss," John warned.

Earlier this month, the Indian government said it had cleared Rs.11.56 billion for the Revised National Tuberculosis Program (RNTCP)-Phase II.

"The RNTCP Phase-II of the World Bank Project has been approved by the government for the period October 2006 to September 2011 for a total outlay of Rs.11.56 billion," Minister of State for Health P. Lakshmi had recently told the Rajya Sabha.


'"/>




Page: 1 2

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Defending against Tuberculosis
3. Easier Tests To Detect Tuberculosis
4. Smoking Increases The Risk Of Developing Tuberculosis Infection
5. Gene Target For Tuberculosis Identified
6. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
7. New Vaccine Targeted At Effective Treatment Against Tuberculosis
8. Time for A.R.Rahman to rock the Tuberculosis Awareness Programme
9. BCG vaccine for both Protection and treatment of Tuberculosis
10. Diagnostic Procedure For Tuberculosis Made Easy
11. PA-824 drug effective against Tuberculosis
Post Your Comments:
(Date:7/9/2008)...l Research Warranted on Impact of Medicare Moderni...enges; Data Shows Possibility of,Longer Wait Times...y 9 /PRNewswire-USNewswire/ -- According to a new ...nal of the American Medical,Association (JAMA), ca...r,access to quality cancer care following the pass...
(Date:7/9/2008)...pneumococcal vaccine (Prevenar) was introduced in ... years later, the experiences have been published ...g decline in serious pneumococcal infections among...that can cause serious illnesses in some young chi...nia. Most of those who become ill are previously h...
(Date:7/9/2008)...c outcome after lumpectomy linked to depression, f...HealthDay News) -- A third of women who opt for br...n asymmetry between their breasts that greatly aff... Women whose affected breast looked noticeably dif...their cancer returning and to have symptoms of dep...
(Date:7/9/2008)...ed MCO Pharmacy Directors Will Move Razadyne and R...dyne is Launched, According to a New ...ass., July 9 /PRNewswire/ -- Decision Resources, o...rms for pharmaceutical and,healthcare issues, find...rtho McNeil,s Razadyne (galantamine) in December 2...
Breaking Medicine News(10 mins):Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2Health News:Vaccinated infants well-protected against severe pneumococcal infection in Norway 2Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3
...ost half of all newly-diagnosed lung cancer cases.... do not disappear as soon as people quit, as it ta...en found that smoking causes genetic damage in the... from becoming cancerous. Researchers from the Uni...
...ched the first two head-to-head clinical trials th...x (alendronate) once weekly 70mg and Actonel (rise...th bisphosphonates indicated for the treatment of ...keted by Aventis and Procter & Gamble through the ...
...n children, which lead to chronic health problems ...ediatricians in the treatment of obesity in childr... kids are getting. A recent study has shown that c...aking them fall short of the American National gui...
...on people go to the Emergency Room(ER) with chest ...t receive an ECG and other standard tests to deter...rious heart problems. However, ECGs can be complet...ce. ECGs are also sometimes unable to identify uns...
Other Medicine News:
(Date:7/8/2008)... SAN MATEO, Calif., July 8 /- After m...ecommended that all new diabetes drugs should,unde... US cardiologists and,65% of US endocrinologists a...etail Inc., a leader in cardiovascular and metabol...mapping solutions to the Global Life,Sciences Indu...
(Date:7/8/2008)... 96-week comparative study of Clevudine versus ...atients with chronic hepatitis B, PRINCETON, N.J....onal,Agency for Research on AIDS and Viral Hepatit...asdaq: VRUS ) and Gilead Sciences, Inc. (Nasdaq: ...y of clevudine and Viread(R),(tenofovir disoproxil...
(Date:7/7/2008)...olecular Biometrics presents scientific evidence s... metabolomics platform at major international ...Spain and CHESTER, N.J., July 7 /- Mo...mics company developing novel,clinical tools for a...ately,characterize biologic function in health and...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performe...t all fruits are created equal when,it comes to th...mong the,highest in bioavailability compared to ot...t small-scale study published in the Journal of th...clude vitamins and phytochemicals called flavonoid...
Breaking Medicine Technology:AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 4Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Kiwifruit: Antioxidant Power in Quantity and Quality 2Childrens Hospital Boston Ranked Number One in New England 20636 1Childrens Hospital Boston Ranked Number One in New England 20636 2Childrens Hospital Boston Ranked Number One in New England 20636 3A common aquatic animals genome can capture foreign DNA 3478 1A common aquatic animals genome can capture foreign DNA 3478 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 1Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 3Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 4Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 5U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 1U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 2
...OLIS, France, May 11, 2007 /PRNewswire-FirstCall/ ...date on the phase 2a,study for NCX 1000, which is ...Pharma Inc. A preliminary analysis of 11 patients...ension confirmed,the safety profile of NCX 1000 bu...port the continuation of this clinical trial. As a...
...tional vaccine could offer protection,for infants ...ococcal disease , , TORONTO, Canada, May 11...results from a,Phase II vaccine clinical study pre...es’ (PAS) Annual Meeting in,Toronto, Canada....-MenCY-TT vaccine holds potential to protect infan...
Other Medicine Technology:NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 2GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 4GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 5
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm.
19 Gauge. Reusable. Block of 4 each.
18 gauge curved. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation.
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the
Medicine Products: